New ALS drug prosetin enters first human safety trials
Disease control
Ongoing
This early-stage study tests whether a new drug, prosetin, is safe for people with ALS (Lou Gehrig's disease) and healthy volunteers. About 72 participants will receive either the drug or a placebo to check for side effects and how the drug moves through the body. The goal is to …
Phase: PHASE1 • Sponsor: ProJenX • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC